Aga Khan University leveraging efforts to develop novel targeted therapies for blood cancer

​AKU’s Centre for Regenerative Medicine and Stem Cell Research (CRM) is leveraging efforts to develop new, targeted therapies for a common form of blood cancer in adults, Philadelphia chromosome positive (Ph+) leukaemia. The aim is to understand the biology of the disease and use this knowledge to develop economically viable therapies. Being a part of the research team, Sujjawal Ahmad conveys his admiration.

The Aga Khan University –University of Ca​​lifornia, San Francisco (UCSF) partnership began a comprehensive and integrated research programme at AKU in stem cell biology and regenerative medicine. Since then, the Centre, under the leadership of Professor Dr El-Nasir M A Lalani , is creating a strong regenerative medicine and stem cell research community across AKU campuses by inducting and training a cadre of clinical researchers, preparing them to undertake ambitious research programmes under the highest ethical, scientific, and medical standards for alleviating disease and improving human health in a state-of-the-art research facility.

Learn more about the research center:

Follow them on LinkedIn:

Learn more about Sujjawal and his work:

Author: Sujjawal Ahmad

Sujjawal is an invited blog author from Pakistan. He finds it extremely exciting to develop a deep love of cultures around the world. The stories that are about humanity, and emotion, that compel us as individuals, and connect our hearts and minds are the kinds of stories Sujjawal has always gravitated to, and the kinds he tells. He can be reached at:

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.